Randy E Metzger

Title: Randy E Metzger: Innovator in Purinergic Receptor Research

Introduction

Randy E Metzger is a notable inventor based in Gurnee, IL (US). He has made significant contributions to the field of purinergic receptors, particularly through his innovative research and patent work. His expertise in this area has led to advancements that may have therapeutic implications.

Latest Patents

Randy E Metzger holds a patent for "Nucleic acids encoding a functional human purinoreceptor P2X2 and P2X4, and methods of production and use thereof." This patent encompasses human P2X and P2X purinergic receptor polypeptides. It includes nucleic acid molecules that encode these receptors, as well as vectors and host cells containing such nucleic acids. The patent also outlines methods for producing these polypeptides and utilizing them to screen for compounds that exhibit activity on P2X receptors. Furthermore, it contemplates therapeutic uses involving these receptors.

Career Highlights

Randy E Metzger is associated with Abbott Laboratories Corporation, where he has been able to apply his research in a practical setting. His work has contributed to the understanding and potential treatment of various conditions related to purinergic signaling.

Collaborations

Throughout his career, Randy has collaborated with notable colleagues such as Tim Van Biesen and Wende Niforatos. These collaborations have likely enhanced the scope and impact of his research.

Conclusion

Randy E Metzger's contributions to the field of purinergic receptors through his patent and work at Abbott Laboratories Corporation highlight his role as an innovator in medical research. His advancements may pave the way for future therapeutic applications.